+44.4%
GSK vs CLBK
+27.8%
+16.6%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CLBK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | -0.5% | +1.1% | +0.5% |
| 7D | +1.1% | +0.9% | +0.2% | +1.1% |
| 30D | +6.3% | +3.4% | +2.9% | +6.2% |
| 3M | +1.8% | -4.3% | +6.1% | +2.0% |
| 6M | +1.7% | +28.4% | -26.7% | +0.4% |
| YTD | +6.5% | +59.4% | -52.9% | +4.3% |
| 1Y | +9.5% | +64.8% | -55.3% | +7.1% |
| 3Y | +65.3% | +50.6% | +14.7% | +60.9% |
| All | +44.4% | +27.8% | +16.6% | +41.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CLBK.
Daily Out/Under-Performance
Portfolio return minus CLBK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLBK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CLBK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling